8-K: Humana Exceeds Medicare Advantage Star Ratings Goal

Humana Inc. announced it has exceeded its goal for 2027 Medicare Advantage Star Ratings, achieving Top Quartile results and reaffirming its 2026 earnings guidance.

Summary

• Humana Inc. reported that it has surpassed its objective for the 2027 Medicare Advantage (MA) Star Ratings, achieving Top Quartile results as defined by CMS data released on October 8, 2026.
• The company's performance means its Stars revenue per member per month (PMPM) is 10% above the peer group median.
• Humana affirms its full-year 2026 adjusted earnings per common share (Adjusted EPS) guidance of at least $9.00.
• The company anticipates that outperformance in Bonus Year 2028 will be partly one-time in nature and will be used for investments and shareholder returns.
• A virtual investor update is scheduled for December 10th, 2026, to review progress against the 2025 Investor Day framework.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a positive development, indicating strong performance in a key business segment and reaffirmation of financial guidance.

Positives

• Exceeded goal of Top Quartile results for 2027 Medicare Advantage Star Ratings.
• Achieved Stars revenue per member per month (PMPM) 10% above the peer group median.
• Reaffirmed 2026 adjusted earnings per common share (Adjusted EPS) guidance of at least $9.00.
• Company believes it is well-positioned to unlock earnings potential by 2028.
• Anticipates a one-time benefit in 2028 from outperformance, to be used for strategic investments and shareholder returns.

Negatives

• The company anticipates some of the outperformance in Bonus Year 2028 relative to Top Quartile will be one-time in nature.
• The company is unable to provide a reconciliation of its FY 2026 Adjusted EPS guidance to GAAP EPS without unreasonable effort due to the ongoing financial close process.
• Potential changes to FY 2026 GAAP EPS guidance are expected due to value creation and strategic initiatives.

Risks

• Forward-looking statements are subject to risks, uncertainties, and assumptions, including those detailed in the Company's SEC filings.
• Actual 2028 Stars revenue PMPM will differ based on actual membership, contract mix, risk scores, benchmark, and rebates.
• The company's management of product and benefit structure assumes performance approximating Top Quartile results, which may not materialize.

Future Outlook

The company expects a one-time benefit in 2028 from outperformance in Bonus Year 2028, which will be utilized for one-time investments and return to shareholders. Humana intends to share more details on this benefit prior to or during its fourth quarter 2027 earnings call when providing detailed 2028 financial guidance. The company believes it is well-positioned to deliver on its commitment of unlocking the earnings potential of the business by 2028.

Management Comments

• The Company intends to manage its product and benefit structure assuming performance that approximates Top Quartile results.
• The Company anticipates some of the outperformance in BY28 relative to Top Quartile will be one time in nature, and it will manage its expenses as such.
• The Company expects a benefit for 2028 that will be utilized for one-time investments and return to shareholders.
• The Company believes it is well positioned to deliver on its commitment of unlocking the earnings potential of the business by 2028 as laid out at its 2025 Investor Day, supported by its expanded membership base, return to Top Quartile Stars results, and continued discipline across pricing, clinical excellence, operating efficiencies and capital allocation.

Industry Context

StockSavvy.ai notes that achieving Top Quartile Medicare Advantage Star Ratings is a critical indicator of quality and financial performance in the health insurance sector, directly impacting revenue through quality bonuses and rebates. Humana's success here suggests strong operational execution and competitive positioning against peers like Centene, CVS, Elevance, HCSC, and United.

Comparison to Industry Standards

• Humana's achievement of Top Quartile results for 2027 Medicare Advantage Star Ratings, defined as Stars revenue PMPM 10% above the peer group median, surpasses the baseline performance of its identified peers (Centene, CVS, Elevance, HCSC, and United).
• The calculation methodology used to normalize for plan design, geographic mix, and membership mix by utilizing a consistent 3.0 benchmark of $1,370, a consistent risk score of 1.15, and consistent benefits equating to a rebate of $222 for all payers, allows for a more direct comparison of quality performance.
• The company's stated goal is to manage its product and benefit structure assuming performance that approximates Top Quartile results, indicating an intent to maintain this high standard.

Stakeholder Impact

• Shareholders: Potential for increased returns through one-time investments and return to shareholders funded by outperformance.
• Employees: Potential for strategic investments that could support long-term company growth and stability.
• Customers: Continued access to quality Medicare Advantage plans, as indicated by strong Star Ratings.

Next Steps

• Hold a virtual investor update on December 10th, 2026, to provide a mark to market against the framework laid out at its 2025 Investor Day.
• Share more information on the level and expected use of the one-time benefit prior to or when giving detailed 2028 financial guidance on the fourth quarter 2027 earnings call.
• Provide detailed 2028 financial guidance on the fourth quarter 2027 earnings call.

Key Dates

Recommendation

The filing indicates strong performance in a key segment (Medicare Advantage Star Ratings) and reaffirms existing earnings guidance. However, the acknowledgment of one-time benefits and the preliminary nature of some financial data suggest a 'hold' position, awaiting further details on the utilization of the one-time benefit and the Q4 2027 earnings call for more concrete 2028 guidance.

Keywords

Medicare Advantage, Star Ratings, CMS, Humana, Health Insurance, Earnings Guidance, PMPM, Investor Update